M-A | Optimal pharmacologic treatment of heart failure with preserved and mildly reduced ejection fraction.
22 Sep, 2022 | 13:05h | UTCRelated M-A: SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials – The Lancet (link to abstract – $ for full-text)